These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30998394)

  • 1. Letter by Sherrid et al Regarding Article, "Bail-Out Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy in a Patient With Takotsubo Cardiomyopathy-Induced Cardiogenic Shock".
    Sherrid MV; Razzouk L; Massera D
    Circ Cardiovasc Interv; 2019 Apr; 12(4):e007977. PubMed ID: 30998394
    [No Abstract]   [Full Text] [Related]  

  • 2. Bail-Out Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy in a Patient With Takotsubo Cardiomyopathy-Induced Cardiogenic Shock.
    Sossalla S; Meindl C; Fischer M; Lubnow M; Müller T; Maier LS
    Circ Cardiovasc Interv; 2019 Feb; 12(2):e007425. PubMed ID: 30722691
    [No Abstract]   [Full Text] [Related]  

  • 3. "Moving left ventricular obstruction" due to stress cardiomyopathy in a patient with hypertrophic obstructive cardiomyopathy treated with percutaneous transluminal septal myocardial ablation.
    Akita K; Maekawa Y; Tsuruta H; Okuda S; Yanagisawa R; Kageyama T; Kawakami T; Kanazawa H; Hayashida K; Yuasa S; Murata M; Jinzaki M; Fukuda K
    Int J Cardiol; 2016 Jan; 202():194-5. PubMed ID: 26397409
    [No Abstract]   [Full Text] [Related]  

  • 4. Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy.
    Fifer MA
    J Am Coll Cardiol; 2018 Dec; 72(24):3095-3097. PubMed ID: 30545447
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter by Batzner et al Regarding Article, "Temporal Occurrence of Arrhythmic Complications After Alcohol Septal Ablation".
    Batzner A; Seggewiss H; Faber L
    Circ Cardiovasc Interv; 2020 Mar; 13(3):e009031. PubMed ID: 32160778
    [No Abstract]   [Full Text] [Related]  

  • 6. Response by El-Sabawi et al to Letter Regarding Article, "Temporal Occurrence of Arrhythmic Complications After Alcohol Septal Ablation".
    El-Sabawi B; Nishimura RA; Eleid MF
    Circ Cardiovasc Interv; 2020 Mar; 13(3):e009059. PubMed ID: 32160780
    [No Abstract]   [Full Text] [Related]  

  • 7. Twenty Years of Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy.
    Rigopoulos AG; Seggewiss H
    Curr Cardiol Rev; 2016; 12(4):285-296. PubMed ID: 25563291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Veselka J; Polaková E; Bonaventura J
    Kardiol Pol; 2019; 77(2):160-161. PubMed ID: 30816984
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Symptomatic Should a Hypertrophic Obstructive Cardiomyopathy Patient Be to Consider Alcohol Septal Ablation?
    Jones BM; Krishnaswamy A; Smedira NG; Desai MY; Tuzcu EM; Kapadia SR
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28512113
    [No Abstract]   [Full Text] [Related]  

  • 11. Alcohol septal ablation in obstructive hypertrophic cardiomyopathy is a safe procedure in experienced hands.
    Seggewiss H; Batzner A
    Rev Port Cardiol (Engl Ed); 2020 Jun; 39(6):305-307. PubMed ID: 32605835
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful percutaneous transluminal septal myocardial ablation through a right superior septal artery for a patient with hypertrophic obstructive cardiomyopathy.
    Kurita T; Tsuchikane E; Tanaka N; Suzuki T
    Cardiovasc Interv Ther; 2015 Oct; 30(4):377-81. PubMed ID: 25502014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous ventricular assist device in hypertrophic obstructive cardiomyopathy with cardiogenic shock: bridge to myectomy.
    Cevik C; Nguyen HU; Civitello AB; Simpson L
    Ann Thorac Surg; 2012 Mar; 93(3):978-80. PubMed ID: 22364991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response by Di Vece et al to Letter Regarding Article, "Outcomes Associated With Cardiogenic Shock in Takotsubo Syndrome: Results From the International Takotsubo Registry".
    Di Vece D; Citro R; Templin C
    Circulation; 2019 Jun; 139(25):e1044-e1045. PubMed ID: 31206329
    [No Abstract]   [Full Text] [Related]  

  • 15. Myectomy for hypertrophic obstructive cardiomyopathy after failed alcohol septal ablation: Clinicopathological correlations. Can J Cardiol 2001;17:197-202.
    Tyers GF
    Can J Cardiol; 2001 Oct; 17(10):1099. PubMed ID: 11706838
    [No Abstract]   [Full Text] [Related]  

  • 16. Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Transcoronary and Endocardial Approach.
    Aksu T; Guler T; Yalin K; Golcuk SE; Ozcan K
    Am J Med Sci; 2016 Nov; 352(5):466-471. PubMed ID: 27865293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of septal myectomy and alcohol septal ablation for hypertrophic cardiomyopathy on the cardiac conduction system.
    Fitzgerald P; Kusumoto F
    J Interv Card Electrophysiol; 2018 Aug; 52(3):403-408. PubMed ID: 30097789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of hypertrophic cardiomyopathy patients for myectomy or alcohol septal ablation.
    Lever HM
    Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():27-30. PubMed ID: 17162266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical management of obstructive hypertrophic cardiomyopathy: the gold standard.
    Brown ML; Schaff HV
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):715-22. PubMed ID: 18510487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a contemporary reappraisal.
    Pelliccia F; Niccoli G; Gragnano F; Limongelli G; Moscarella E; Andò G; Esposito A; Stabile E; Ussia GP; Tarantini G; Gimeno JR; Elliott P; Calabrò P
    EuroIntervention; 2019 Aug; 15(5):411-417. PubMed ID: 30860070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.